Monica Perlman

Scripps Health — United States

Medicine · Health Sciences

4h-index270citations6works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory mediators and NSAID effects(4), Estrogen and related hormone effects(2), Skin Protection and Aging(2), Asthma and respiratory diseases(1), Pharmacogenetics and Drug Metabolism(1)

Publications6 total

Tolerability of Rofecoxib versus Naproxen
Annals of Internal Medicine·2004
Gastrointestinal Tolerability and Effectiveness of Rofecoxib versus Naproxen in the Treatment of Osteoarthritis
Annals of Internal Medicine·2003· 149 cited
SAT0096 Gastrointestinal tolerability in primary care patients treated with naproxen or rofecoxib for osteoarthritis (oa): the advantage trial
Annals of the Rheumatic Diseases·2001· 5 cited
A comparison of the gastrointestinal (GI) tolerability of rofecoxih 25 Mg Qd Vs naproxen 500 Mg bid in the treatment of osteoarthritis (OA): The “Advantage” trial
Gastroenterology·2001
American college of preventive medicine practice policy statement
American Journal of Preventive Medicine·1998· 67 cited
American college of preventive medicine policy statement: Screening for skin cancer
American Journal of Preventive Medicine·1998· 49 cited

Frequent Co-authors

Jeffrey Lisse(3), Adam B. Polis(3), Gregory P. Geba(3), Gunnar Johansson(2), Joy Schechtman(2), Carol S. Skalky(2), Mary Dixon(2), Rebecca Ferrini(2), James R. Shoemaker(1), Arthur J. Mollen(1), Linda Hill(1), Linda Hill(1), GP Geba(1), JR Lisse(1), AB Polis(1), ME Dixon(1), CS Skalky(1), Thomas W Dobbins(1), JR Shoemaker(1), AJ Mollen(1)